Semaphorins at the Interface of Development and Cancer

E-ISSN： 1873-5592|10|7|611-619

ISSN： 1389-4501

Source： Current Drug Targets, Vol.10, Iss.7, 2009-07, pp. : 611-619

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Semaphorins and their Receptors in Stem and Cancer Cells

Current Medicinal Chemistry, Vol. 17, Iss. 30, 2010-10 ,pp. : 3462-3475

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer vaccine development

By Schlom J. Tsang K-Y. Kantor J.A. Abrams S.I. Zaremba S. Greiner J. Hodge J.W.

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 9, 1998-09 ,pp. : 1439-1452

Informa Healthcare

Access to resources Recommend Favorite

Ubiquitylation and Cancer Development

Current Cancer Drug Targets, Vol. 8, Iss. 2, 2008-03 ,pp. : 118-123

Bentham Science Publishers

Access to resources Recommend Favorite

Ligand-Protein Docking: Cancer Research at the Interface between Biology and Chemistry

Current Medicinal Chemistry, Vol. 10, Iss. 9, 2003-05 ,pp. : 763-777

Bentham Science Publishers

Access to resources Recommend Favorite

Complement: An Inflammatory Pathway Fulfilling Multiple Roles at the Interface of Innate Immunity and Development

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 1, 2005-01 ,pp. : 125-127

Bentham Science Publishers

Access to resources Recommend Favorite